Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIRS NASDAQ:AVAH NYSE:TDOC NASDAQ:VRDN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$6.45-3.2%$5.86$1.53▼$9.20$415.83M2.5842,796 shs434,367 shsAVAHAveanna Healthcare$8.00+2.0%$5.26$3.67▼$8.04$1.64B1.951.98 million shs1.77 million shsTDOCTeladoc Health$7.74-1.9%$7.81$6.35▼$15.21$1.39B1.766.03 million shs3.53 million shsVRDNViridian Therapeutics$18.38-0.3%$16.94$9.90▼$27.20$1.51B0.42860,372 shs649,738 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies-3.15%-0.77%+5.05%+45.60%+54.68%AVAHAveanna Healthcare+2.04%+7.10%+100.50%+49.25%+48.15%TDOCTeladoc Health-1.96%+0.86%+4.45%+11.85%+12.99%VRDNViridian Therapeutics-0.33%-4.42%+3.26%+33.28%+23.52%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIRSAirSculpt Technologies0.7968 of 5 stars1.02.00.00.03.33.30.0AVAHAveanna Healthcare2.413 of 5 stars2.34.00.00.03.32.50.6TDOCTeladoc Health2.9887 of 5 stars3.23.00.00.02.52.51.3VRDNViridian Therapeutics1.9266 of 5 stars4.50.00.00.03.00.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIRSAirSculpt Technologies 2.00Hold$3.75-41.86% DownsideAVAHAveanna Healthcare 2.60Moderate Buy$7.50-6.25% DownsideTDOCTeladoc Health 2.35Hold$9.8026.57% UpsideVRDNViridian Therapeutics 2.90Moderate Buy$37.78105.54% UpsideCurrent Analyst Ratings BreakdownLatest AIRS, VRDN, AVAH, and TDOC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/25/2025VRDNViridian TherapeuticsJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$44.008/19/2025AVAHAveanna HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$5.50 ➝ $9.508/19/2025AVAHAveanna HealthcareUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeSell ➝ Neutral$6.75 ➝ $8.008/12/2025AVAHAveanna HealthcareUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSell ➝ Sell$5.00 ➝ $6.758/11/2025AVAHAveanna HealthcareRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$9.008/7/2025VRDNViridian TherapeuticsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$27.00 ➝ $30.008/7/2025VRDNViridian TherapeuticsRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$45.00 ➝ $41.008/7/2025VRDNViridian TherapeuticsWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$27.00 ➝ $26.008/7/2025VRDNViridian TherapeuticsOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$28.00 ➝ $32.008/6/2025VRDNViridian TherapeuticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$36.00 ➝ $34.007/25/2025TDOCTeladoc HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$10.00(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIRSAirSculpt Technologies$165.11M2.44$0.16 per share39.71$1.46 per share4.42AVAHAveanna Healthcare$2.18B0.77$0.17 per share47.81($0.06) per share-133.33TDOCTeladoc Health$2.57B0.53$5.49 per share1.41$8.05 per share0.96VRDNViridian Therapeutics$300K5,003.04N/AN/A$4.00 per share4.60Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIRSAirSculpt Technologies-$8.25M-$0.25N/A∞N/A-8.79%-15.63%-6.30%11/14/2025 (Estimated)AVAHAveanna Healthcare-$10.93M$0.08100.00∞N/A0.85%-54.56%3.17%11/6/2025 (Estimated)TDOCTeladoc Health-$1.00B-$1.19N/AN/AN/A-8.16%-10.13%-4.43%10/29/2025 (Estimated)VRDNViridian Therapeutics-$269.95M-$3.83N/AN/AN/A-112,806.88%-78.95%-49.91%11/11/2025 (Estimated)Latest AIRS, VRDN, AVAH, and TDOC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025VRDNViridian Therapeutics-$1.00-$1.00N/A-$1.00$0.05 million$0.08 million8/1/2025Q2 2025AIRSAirSculpt Technologies$0.02$0.02N/A-$0.01$45.59 million$44.01 million7/29/2025Q2 2025TDOCTeladoc Health-$0.27-$0.19+$0.08-$0.19$621.91 million$631.90 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIRSAirSculpt TechnologiesN/AN/AN/AN/AN/AAVAHAveanna HealthcareN/AN/AN/AN/AN/ATDOCTeladoc HealthN/AN/AN/AN/AN/AVRDNViridian TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIRSAirSculpt Technologies0.580.640.64AVAHAveanna HealthcareN/A1.091.09TDOCTeladoc Health0.702.672.58VRDNViridian Therapeutics0.0411.0111.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIRSAirSculpt Technologies91.54%AVAHAveanna Healthcare87.96%TDOCTeladoc Health76.82%VRDNViridian TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipAIRSAirSculpt Technologies76.58%AVAHAveanna Healthcare7.80%TDOCTeladoc Health0.58%VRDNViridian Therapeutics1.58%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIRSAirSculpt Technologies24062.44 million14.62 millionOptionableAVAHAveanna Healthcare33,500208.90 million192.60 millionOptionableTDOCTeladoc Health5,500176.69 million175.67 millionOptionableVRDNViridian Therapeutics5081.66 million80.37 millionOptionableAIRS, VRDN, AVAH, and TDOC HeadlinesRecent News About These Companies248,628 Shares in Viridian Therapeutics, Inc. $VRDN Purchased by Nuveen LLC4 hours ago | marketbeat.comAffinity Asset Advisors LLC Has $5.26 Million Stock Holdings in Viridian Therapeutics, Inc. $VRDNAugust 28 at 9:02 AM | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of "Moderate Buy" from BrokeragesAugust 28 at 5:21 AM | marketbeat.comViridian Therapeutics (NASDAQ:VRDN) Now Covered by Analysts at Jefferies Financial GroupAugust 27 at 10:05 AM | marketbeat.com13,742 Shares in Viridian Therapeutics, Inc. $VRDN Purchased by EntryPoint Capital LLCAugust 27 at 4:27 AM | marketbeat.comRussell Investments Group Ltd. Sells 181,338 Shares of Viridian Therapeutics, Inc. $VRDNAugust 27 at 3:46 AM | marketbeat.comViridian Therapeutics (NASDAQ:VRDN) Coverage Initiated at Jefferies Financial GroupAugust 27 at 2:45 AM | americanbankingnews.comAlgert Global LLC Sells 50,850 Shares of Viridian Therapeutics, Inc. $VRDNAugust 26, 2025 | marketbeat.comViridian Therapeutics, Inc. $VRDN Stake Cut by Vanguard Group Inc.August 26, 2025 | marketbeat.comViridian Therapeutics, Inc. $VRDN Shares Purchased by Candriam S.C.A.August 24, 2025 | marketbeat.comViridian Therapeutics (NASDAQ:VRDN) & Y-mAbs Therapeutics (NASDAQ:YMAB) Critical AnalysisAugust 21, 2025 | americanbankingnews.comHC Wainwright Issues Optimistic Estimate for VRDN EarningsAugust 11, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Outlook for VRDN EarningsAugust 11, 2025 | marketbeat.comLifesci Capital Has Negative Estimate for VRDN Q3 EarningsAugust 11, 2025 | marketbeat.comWedbush Research Analysts Boost Earnings Estimates for VRDNAugust 11, 2025 | marketbeat.comWedbush Lowers Earnings Estimates for Viridian TherapeuticsAugust 9, 2025 | marketbeat.comViridian Therapeutics (NASDAQ:VRDN) Posts Earnings Results, Hits ExpectationsAugust 9, 2025 | marketbeat.comThe Goldman Sachs Group Issues Positive Forecast for Viridian Therapeutics (NASDAQ:VRDN) Stock PriceAugust 8, 2025 | marketbeat.comViridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $41.00 at Royal Bank Of CanadaAugust 8, 2025 | marketbeat.comViridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $26.00 at Wells Fargo & CompanyAugust 8, 2025 | marketbeat.comOppenheimer Increases Viridian Therapeutics (NASDAQ:VRDN) Price Target to $32.00August 8, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAIRS, VRDN, AVAH, and TDOC Company DescriptionsAirSculpt Technologies NASDAQ:AIRS$6.45 -0.21 (-3.15%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$6.46 +0.01 (+0.16%) As of 08/29/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.Aveanna Healthcare NASDAQ:AVAH$8.00 +0.16 (+2.04%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$8.05 +0.05 (+0.63%) As of 08/29/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Teladoc Health NYSE:TDOC$7.74 -0.15 (-1.90%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$7.72 -0.02 (-0.31%) As of 08/29/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.Viridian Therapeutics NASDAQ:VRDN$18.38 -0.06 (-0.33%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$18.40 +0.02 (+0.08%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It 3 Reasons Gartner Could Be the Best Buy of Q3 NIO Just Got Its Second Upgrade of the Month, and It’s Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
